Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daoxin Ma, Yuanchao Zhu, Chunyan Ji & Ming Hou. (2010) Targeting the Notch signaling pathway in autoimmune diseases. Expert Opinion on Therapeutic Targets 14:5, pages 553-565.
Read now
Read now
Articles from other publishers (28)
Serena D’Souza, Arati Mane, Linata Patil, Aazam Shaikh, Madhuri Thakar, Vandana Saxena, Leila Fotooh Abadi, Sheela Godbole, Smita Kulkarni, Raman Gangakhedkar, Padma Shastry & Samiran Panda. (2023) HIV-1 exploits Hes-1 expression during pre-existing HPV-16 infection for cancer progression. VirusDisease 34:1, pages 29-38.
Crossref
Crossref
Wenfeng Liao, Xiaodong Hu, Zhenyun Du, Peipei Wang & Kan Ding. (2022) A homogalacturonan from Lonicera japonica Thunb. disrupts angiogenesis via epidermal growth factor receptor and Delta-like 4 associated signaling. Glycoconjugate Journal 39:6, pages 725-735.
Crossref
Crossref
Esra Küpeli Akkol, Hilal Bardakci, Timur Hakan Barak, Michael Aschner, Gökçe Şeker Karatoprak, Haroon Khan & Yaseen Hussain. (2022) Herbal Ingredients in the Prevention of Breast Cancer: Comprehensive Review of Potential Molecular Targets and Role of Natural Products. Oxidative Medicine and Cellular Longevity 2022, pages 1-23.
Crossref
Crossref
Jing-Wen Bai, Min Wei, Ji-Wei Li & Guo-Jun Zhang. (2020) Notch Signaling Pathway and Endocrine Resistance in Breast Cancer. Frontiers in Pharmacology 11.
Crossref
Crossref
Munmun Panda & Bijesh K. Biswal. (2019) Cell signaling and cancer: a mechanistic insight into drug resistance. Molecular Biology Reports 46:5, pages 5645-5659.
Crossref
Crossref
Micaela Montanari, Maria Rita Carbone, Luigi Coppola, Mario Giuliano, Grazia Arpino, Rossella Lauria, Agostina Nardone, Felicia Leccia, Meghana V. Trivedi, Corrado Garbi, Roberto Bianco, Enrico V. Avvedimento, Sabino De Placido & Bianca Maria Veneziani. (2019)
Epigenetic Silencing of
THY1
Tracks the Acquisition of the Notch1–EGFR Signaling in a Xenograft Model of CD44
+
/CD24
low
/CD90
+
Myoepithelial Cells
. Molecular Cancer Research 17:2, pages 628-641.
Crossref
Crossref
Samer J. Hanna, Kessler McCoy-Simandle, Edison Leung, Alessandro Genna, John Condeelis & Dianne Cox. (2019) Tunneling nanotubes, a novel mode of tumor cell-macrophage communication in tumor cell invasion. Journal of Cell Science.
Crossref
Crossref
Yang Zheng, Zhao Wang, Xu Ding, Wei Zhang, Gang Li, Laikui Liu, Heming Wu, Wenyi Gu, Yunong Wu & Xiaomeng Song. (2018) A novel Notch1 missense mutation (C1133Y) in the Abruptex domain exhibits enhanced proliferation and invasion in oral squamous cell carcinoma. Cancer Cell International 18:1.
Crossref
Crossref
Yang Zheng, Zhao Wang, Xu Ding, Yibo Dong, Wei Zhang, Wei Zhang, Yi Zhong, Wenyi Gu, Yunong Wu & Xiaomeng Song. (2017) Combined Erlotinib and PF‐03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma. Cell Proliferation 51:3.
Crossref
Crossref
Sherif Abdelaziz Ibrahim, Ramy Gadalla, Eslam A. El-Ghonaimy, Omnia Samir, Hossam Taha Mohamed, Hebatallah Hassan, Burkhard Greve, Mohamed El-Shinawi, Mona Mostafa Mohamed & Martin Götte. (2017) Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways. Molecular Cancer 16:1.
Crossref
Crossref
Katherine M. Morgan, Bruce S. Fischer, Francis Y. Lee, Jamie J. Shah, Joseph R. Bertino, Jeffrey Rosenfeld, Amartya Singh, Hossein Khiabanian & Sharon R. Pine. (2017) Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma. Molecular Cancer Therapeutics 16:12, pages 2759-2769.
Crossref
Crossref
Zhihong Sun, Cheng Zhou, Feng Liu, Wenchao Zhang, Jing Chen, Yanlong Pan, Lianqing Ma, Qimin Liu, Yuping Du, Jinbo Yang & Qin Wang. (2017) Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in�vivo and in�vitro. Oncology Letters.
Crossref
Crossref
Yu-Chae Jung, Seula Han, Li Hua, Yeon-Hwa Ahn, Hyewon Cho, Cheol-Jung Lee, Hani Lee, Yong-Yeon Cho, Jae-Ha Ryu, Raok Jeon & Woo-Young Kim. (2016) Kazinol-E is a specific inhibitor of ERK that suppresses the enrichment of a breast cancer stem-like cell population. Biochemical and Biophysical Research Communications 470:2, pages 294-299.
Crossref
Crossref
Efstathia Giannopoulou, Achilleas Nikolakopoulos, Dimitra Kotsirilou, Angeliki Lampropoulou, Sofia Raftopoulou, Evangelia Papadimitriou, Achilleas D. Theocharis, Thomas Makatsoris, Konstantinos Fasseas & Haralabos P. Kalofonos. (2015) Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells. Journal of Biomedical Science 22:1.
Crossref
Crossref
He-da Zhang, Da-wei Sun, Ling Mao, Jun Zhang, Lin-hong Jiang, Jian Li, Ying Wu, Hao Ji, Wei Chen, Jing Wang, Rong Ma, Hai-xia Cao, Jian-zhong Wu & Jin-hai Tang. (2015) MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochemical and Biophysical Research Communications 465:4, pages 702-713.
Crossref
Crossref
Stephan Lindsey & Sigrid A. Langhans. 2015.
1
41
.
XUEZHEN LI, XIN HE, WEI TIAN & JIANZHEN WANG. (2014) Short hairpin RNA targeting Notch2 inhibits U87 human glioma cell proliferation by inducing cell cycle arrest and apoptosis in vitro and in vivo. Molecular Medicine Reports 10:6, pages 2843-2850.
Crossref
Crossref
Hui‑Ping Yu, Song‑Tao Qi, Wen‑Feng Feng, Guo‑Zhong� Zhang, He‑Ping Zhang & Jin‑Jun Tian. (2014) Interference of Notch 2 inhibits the progression of gliomas and induces cell apoptosis by induction of the cell cycle at the G0/G1 phase. Molecular Medicine Reports.
Crossref
Crossref
Armel Hervé Nwabo Kamdje. (2014) New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers. World Journal of Clinical Cases 2:12, pages 769.
Crossref
Crossref
Weiqiang Zhou, Guangdi Wang & Shanchun Guo. (2013) Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 304-320.
Crossref
Crossref
Paola Ferrari, Andrea Nicolini & Angelo Carpi. (2013) Targeted therapies of metastatic breast cancer: Relationships with cancer stem cells. Biomedicine & Pharmacotherapy 67:6, pages 543-555.
Crossref
Crossref
Shanchun Guo, Mingli Liu, Guangdi Wang & Lily Yang. 2013. Tumor Angiogenesis Regulators. Tumor Angiogenesis Regulators
37
90
.
Paola Ferrari & Andrea Nicolini. (2012) Breast cancer stem cells: new therapeutic approaches. Breast Cancer Management 1:4, pages 277-294.
Crossref
Crossref
Axel Schulenburg & Brigitte Marian. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Fares Al-Ejeh, Chanel E. Smart, Brian J. Morrison, Georgia Chenevix-Trench, J. Alejandro López, Sunil R. Lakhani, Michael P. Brown & Kum Kum Khanna. (2011) Breast cancer stem cells: treatment resistance and therapeutic opportunities. Carcinogenesis 32:5, pages 650-658.
Crossref
Crossref
Shanchun Guo, Mingli Liu & Ruben R. Gonzalez-Perez. (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:2, pages 197-213.
Crossref
Crossref
Naoko Takebe, Pamela J. Harris, Ronald Q. Warren & S. Percy Ivy. (2010) Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Reviews Clinical Oncology 8:2, pages 97-106.
Crossref
Crossref
Zhiwei Wang, Yiwei Li, Aamir Ahmad, Asfar S. Azmi, Sanjeev Banerjee, Dejuan Kong & Fazlul H. Sarkar. (2010) Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1806:2, pages 258-267.
Crossref
Crossref